NDC 0409-1391-21 - Meropenem
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-1391
- Requested NDC
- 0409-1391-21
- Package NDCs from labels
- 0409-1391-21, 0409-1391-22
- Manufacturer
- Hospira, Inc.
- Effective date
- 2024-11-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Meropenem - Hospira, Inc. | Hospira, Inc. | 2024-11-06 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0409-1391-21 | Meropenem | 20 mL in 1 VIAL | INJECTION, POWDER, FOR SOLUTION | 20 | 7 | |
| 0409-1391-22 | Meropenem | 10 in 1 CARTON | INJECTION, POWDER, FOR SOLUTION | 10 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0409-1391-21 | EA - Each | 0409-1391 | e585938d-28f1-4078-a24d-cc2a06f83978 | 1 | 2019-11-12 |
| 0409-1391-22 | EA - Each | 0409-1391 | 27b545cb-a947-40e7-af69-dffbaeed572d | 1 | 2019-11-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Meropenem | MEROPENEM | WG Critical Care, LLC | 6520ae3d-e149-499c-8152-36f6ab861662 | 2021-06-30 | Warnings, Adverse reactions | 1722934 1722939 FV9J3JU8B1 |
| Meropenem | MEROPENEM | Fresenius Kabi USA, LLC | 12714f80-d6e5-4453-b66c-62f57c16ddfc | 2021-03-12 | Warnings, Adverse reactions | ANDA091404 1722934 1722939 FV9J3JU8B1 |
| Meropenem | MEROPENEM | Fresenius Kabi USA, LLC | 7a68d899-2678-43a9-a9c1-ef8f916b562f | 2021-03-10 | Warnings, Adverse reactions | ANDA091404 1722934 1722939 FV9J3JU8B1 |
| Meropenem | MEROPENEM | Fresenius Kabi USA, LLC | 185181e3-c004-4d61-b992-5df94fe57a90 | 2020-10-19 | Warnings, Adverse reactions | ANDA091404 1722934 1722939 FV9J3JU8B1 |
| Meropenem | MEROPENEM | WG Critical Care, LLC | 74ff19b5-6156-4a27-affb-744b0ce1aeec | 2020-05-29 | Warnings, Adverse reactions | 1722934 1722939 FV9J3JU8B1 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.